We here present the long-term thymus- and T-dependent immunity-preserving effect of systemic (genetic) loss of PPARgamma function as observed in PPARgamma deficient mouse models and in a human rare disease (FPLD3). This evidence concerns the gene PPARG and PPARG-related familial partial lipodystrophy.